Elacestrant in Advanced Triple Positive Breast Cancer

Clinical trial NCT07612215 · RECRUITING

Trial details

NCT number: NCT07612215
Sponsor: NYU Langone Health
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

ER Positive, HER2 Positive Breast Cancer

Start date: 2026-05-13
Primary completion: 2029-05-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.